𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Molecular signatures of metastasis in head and neck cancer

✍ Scribed by Stefano Colella; Kristy L. Richards; Linda L. Bachinski; Keith A. Baggerly; Spiridon Tsavachidis; James C. Lang; David E. Schuller; Ralf Krahe

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
373 KB
Volume
30
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background.

Metastases are the primary cause of cancer treatment failure and death, yet metastatic mechanisms remain incompletely understood.

Methods.

We studied the molecular basis of head and neck cancer metastasis by transcriptionally profiling 70 samples from 27 patients—matching normal adjacent tissue, primary tumor, and cervical lymph node metastases.

Results.

We identified tumor‐associated expression signatures common to both primary tumors and metastases. Use of matching metastases revealed an additional 46 dysregulated genes associated solely with head and neck cancer metastasis. However, despite being metastasis‐specific in our sample set, these 46 genes are concordant with genes previously discovered in primary tumors that metastasized.

Conclusions.

Although our data and related studies show that most of the metastatic potential appears to be inherent to the primary tumor, they are also consistent with the notion that a limited number of additional clonal changes are necessary to yield the final metastatic cell(s), albeit in a variable temporal order. © 2008 Wiley Periodicals, Inc. Head Neck 2008

📜 SIMILAR VOLUMES

Molecular pathology of head-and-neck can
Molecular pathology of head-and-neck cancer
✍ Michael M. Kim; Joseph A. Califano 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 113 KB 👁 1 views

## Abstract Each year approximately 40,000 people in the United States and 500,000 people worldwide are diagnosed with head‐and‐neck squamous cell carcinoma (HNSC). Although there have been significant improvements in the treatment of this disease, leading to decreased morbidity, over the past few

Genetic abnormalities associated with no
Genetic abnormalities associated with nodal metastasis in head and neck cancer
✍ Volkert B. Wreesmann; Dorothy Wang; Andy Goberdhan; Mukesh Prasad; Ivan Ngai; Er 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 354 KB 👁 1 views

## Abstract ## Background. Lymphatic metastasis represents the single most important clinical prognostic factor in head and neck squamous cell carcinoma (HNSCC), but underlying genetic mechanisms remain ill defined. Genetic differences between primary carcinomas and their corresponding metastases

New molecular diagnostic methods in head
New molecular diagnostic methods in head and neck cancer
✍ Juan Pablo Rodrigo; Alfio Ferlito; Carlos Suárez; Ashok R. Shaha; Carl E. Silver 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB 👁 2 views

Initial cancer evaluation includes assessment of histologic appearance, tumor grading, assessment of lymph node status, and presence of metastasis. However, traditional diagnostic methods such as histopathology and radiology are not sensitive enough to detect small numbers of cancer cells and are li

Molecular support for field cancerizatio
Molecular support for field cancerization in the head and neck
✍ William M. Lydiatt; Peter E. Anderson; Tullia Bazzana; Michelle Casale; Christop 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

## Background: Two competing concepts, field cancerization and micrometastatic lesions, have been postulated to account for the high frequency of second primary tumors and multicentric dysplasia in patients with head and neck carcinoma. ## Methods: To provide insight into this process, the author

Development of distant metastasis after
Development of distant metastasis after treatment of advanced-stage head and neck cancer
✍ Aijaz Alvi; Jonas T. Johnson 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 41 KB 👁 2 views

## Background: The recognition of risk factors for the development of distant metastasis is necessary for identifying high-risk patients who may benefit from systemic therapy. previous investigations studying possible risk factors have been heterogeneous, with patients having varied forms of therap